Experience

• • TPG and OneOncology, a national platform for independent oncology, urology and radiation oncology, in OneOncology’s partnership with Cancer Specialists of North Florida, a provider-owned oncology practice.
  • Brighthouse Financial in its approximately $4.1 billion sale to Aquarian Capital, a diversified global holding company.
  • TPG and OneOncology, a national platform for independent oncology, urology and radiation oncology, in OneOncology’s acquisition of GenesisCare USA of Florida, an integrated cancer care provider, to be relaunched as SunState Medical Specialists.
  • Fédération Française de Tennis as a defendant in a class-action antitrust lawsuit brought by The Professional Tennis Players Association and several tennis players in the Southern District of New York.
  • Roku, a U.S. streaming platform, in its acquisition of Frndly TV, a subscription streaming service.
  • Mitsui Sumitomo Insurance Company, a subsidiary of MS&AD Insurance Group Holdings, in its agreement with the founding family of W. R. Berkley Corporation, a leading property and casualty insurance carrier, including acquisition of 15% of shares in W. R. Berkley Corporation in a transaction valued at approximately $3.8 billion.
  • Clayton, Dubilier & Rice in its investment in Columbus McKinnon to fund Columbus McKinnon’s $2.7 billion acquisition of Kito Crosby.
  • Oaktree Capital Management and Velocity Risk in the $525 million sale of Velocity Risk to Ryan Specialty, and sale of Velocity Specialty Insurance Company to FM, from funds managed by Oaktree.
  • TPG Growth, the middle market and growth equity platform of TPG, in its acquisition of a minority stake in Homrich Berg.
  • Verizon in its $20 billion acquisition of Frontier, the largest pure-play fiber internet provider in the U.S.
  • TPG and OneOncology in OneOncology’s acquisition of United Urology Group.
  • Clayton, Dubilier & Rice in its $2.1 billion sale of Cheney, a foodservice distributor, to Performance Food Group, a foodservice distribution company.
  • Clayton, Dubilier & Rice in its acquisition, together with TowerBrook, of R1 RCM, a provider of technology-driven solutions that impact the patient experience and financial performance of healthcare providers, at an enterprise value of $8.9 billion.
  • Dover Corporation in its $395 million acquisition of Marshall Excelsior, a provider of mission-critical cryogenic and flow control components.
  • Hamilton Lane in the acquisition of a significant equity interest in Cosette Pharmaceuticals from Avista and its co-investors through funds managed by Hamilton Lane.